Serum high-density lipoprotein cholesterol, metabolic profile, and breast cancer risk.
about
Metabolic syndrome is associated with increased breast cancer risk: a systematic review with meta-analysisApolipoprotein A-I and CancerData-Driven Metabolic Pathway Compositions Enhance Cancer Survival Prediction.Metabolic syndrome and postmenopausal breast cancer in the ORDET cohort: a nested case-control studyBreast cancer and metabolic syndrome linked through the plasminogen activator inhibitor-1 cycleSerum lipid levels and the risk of biliary tract cancers and biliary stones: A population-based study in China.The cholesterol metabolite 25-hydroxycholesterol activates estrogen receptor α-mediated signaling in cancer cells and in cardiomyocytesAssociation of metabolic syndromes and risk factors with ampullary tumors development: a case-control study in China.Sex-specific HDL cholesterol changes with weight loss and their association with anthropometric variables: the LIFE study.Metabolic syndrome and mammographic density in Mexican womenHDL cholesterol and cancer risk among patients with type 2 diabetes.Metabolic syndrome biomarkers and early breast cancer in Saudi women: evidence for the presence of a systemic stress response and/or a pre-existing metabolic syndrome-related neoplasia risk?The role of high-density lipoproteins in reducing the risk of vascular diseases, neurogenerative disorders, and cancer.The dyslipidemia-associated SNP on the APOA1/C3/A5 gene cluster predicts post-surgery poor outcome in Taiwanese breast cancer patients: a 10-year follow-up studyGene variations in oestrogen pathways, CYP19A1, daily 17β-estradiol and mammographic density phenotypes in premenopausal women.Carcinoembryonic antigen level can be overestimated in metabolic syndrome.Plasma level of LDL-cholesterol at diagnosis is a predictor factor of breast tumor progression.The link between the metabolic syndrome and cancer.Resistin, visfatin, adiponectin, and leptin: risk of breast cancer in pre- and postmenopausal saudi females and their possible diagnostic and predictive implications as novel biomarkers.Serum CA125 concentration has inverse correlation with metabolic syndrome.The metabolic syndrome: A high-risk state for cancer?Correlation Between Obesity and High Density Lipoprotein Cholesterol (HDL-C) in Breast Cancer Patients of Southern Rajasthan.Effects of statin use on volumetric mammographic density: results from the KARMA study.Serum Lipids and Breast Cancer Risk: A Meta-Analysis of Prospective Cohort Studies.Hypochlorite-induced oxidative stress elevates the capability of HDL in promoting breast cancer metastasis.The metabolic syndrome and mammographic breast density in a racially diverse and predominantly immigrant sample of womenThe Valuable Role of Measuring Serum Lipid Profile in Cancer Progression.Clinical significance of preoperative serum high density lipoprotein cholesterol levels in soft tissue sarcoma.Association of endothelin-1 and matrix metallopeptidase-9 with metabolic syndrome in middle-aged and older adults.27-hydroxycholesterol is an endogenous selective estrogen receptor modulatorObesity, HDL and Breast Cancer.Prediagnostic total and high-density lipoprotein cholesterol and risk of cancerSerum lipid profiles and cancer risk in the context of obesity: four meta-analyses.Lipoprotein subfractions by nuclear magnetic resonance are associated with tumor characteristics in breast cancer.Metabolic syndrome and mammographic density: the Study of Women's Health Across the Nation.Serum lipids, lipoproteins, and risk of breast cancer: a nested case-control study using multiple time points.Metabolic profile of breast cancer in a population of women in southern Spain.The role of chronic inflammation in obesity-associated cancers.HDL-cholesterol and incidence of breast cancer in the ARIC cohort study.Cardiometabolic factors and breast cancer risk in U.S. black women.
P2860
Q23920590-59395776-C073-4C62-BDF5-FD526E166AFEQ26776188-AC3E405B-48E3-41A8-9E3B-8DEF02FD56ACQ31133387-774A8FC4-BB6E-46FA-BF5C-B250FF7B4B6EQ33643001-C8B7E9CA-EE89-46A3-88CC-97A72C6D8C7CQ33715393-F651780D-C3DC-429C-9E3C-540DD33F9CCCQ33814914-52721E2B-CCD4-430A-92DA-1A970155C7DBQ33815579-A0FED9E1-C9E4-4B11-92E3-F4AA727F7788Q33948411-FED0B612-9A35-4980-A5F7-6038DA611C9CQ34486587-4CE609E7-C515-440B-A62C-1E115E48876DQ34488889-A5038EA5-B429-4BAE-A5B8-E4B78B3535B0Q34545361-5073A76B-CE02-48CE-8DD5-BC6F036A5342Q34572361-4EF36CF5-F1E3-4850-B728-B7A3AB1C5F5CQ34730815-F476DD87-7014-4EBD-A268-789461E3FA9BQ34799703-C6FD54D5-5414-4FFE-871B-1D42E3846FD5Q35000723-F13E7888-DB6C-4A65-9F34-66CE8602929BQ35009846-B5FF088D-7418-47C7-9C6D-7B10FF96FDD2Q35103289-7098C424-1DAD-4BDC-8670-5DA9DA4482C4Q35187561-CE968D83-A302-414F-B0C0-EC2B5A58A5ECQ35206787-949417FE-05B3-4404-81D5-A67EDB2D9169Q35333807-A3193A07-6650-46D9-B6E2-71DB2A8591FEQ35607405-AD49B8D3-9D9B-46A4-92EB-DE3B4C0BE656Q35628081-02E2CA8C-C992-4B67-B0E4-6A4D6553110EQ35643266-61457844-51DA-44C0-A722-0D5783B6029EQ35836964-CD9A5E16-F26A-4C30-B0EB-3BF47C4D2E36Q35927813-1007C9F4-1767-4DE9-8651-C323E3DA62A6Q36054359-95758114-3026-4DCA-844B-EDC882B0ECE9Q36076874-7CB22F6C-40F5-475A-B4C5-35F0B411F858Q36151318-A5D1FE09-8C0F-481D-A139-BAE792D5CCAAQ36364214-1037277E-5364-408C-93A2-EEB86DDF519DQ36372645-B2A2D83E-847A-48D2-93D3-1B24D94CDACBQ36464684-845238FE-A066-49BB-9392-D7321D05B300Q36501079-99FB5842-D4FA-475A-B0FA-DEBDD19775A8Q36584255-352FEC79-3F52-4948-994A-FDC1A5D7EF0CQ36680439-E1D7F2F7-E8C6-46AD-9CFF-2096D86827BEQ36723813-8B787629-E7E2-4854-AAF0-042A78E7AA42Q36770247-62481B45-9103-4AF9-A5C3-340644977520Q36798413-1D957356-B01F-4271-9349-7ADFAC10BA3FQ36931512-1E7E90DF-86E3-4383-AE86-5EB31ECA15E4Q36934633-28B57E56-D558-45DF-BB22-390730C2967AQ36942881-07FE2025-D040-4F06-85B8-F4BB9A9FD29E
P2860
Serum high-density lipoprotein cholesterol, metabolic profile, and breast cancer risk.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
Serum high-density lipoprotein cholesterol, metabolic profile, and breast cancer risk.
@en
Serum high-density lipoprotein cholesterol, metabolic profile, and breast cancer risk.
@nl
type
label
Serum high-density lipoprotein cholesterol, metabolic profile, and breast cancer risk.
@en
Serum high-density lipoprotein cholesterol, metabolic profile, and breast cancer risk.
@nl
prefLabel
Serum high-density lipoprotein cholesterol, metabolic profile, and breast cancer risk.
@en
Serum high-density lipoprotein cholesterol, metabolic profile, and breast cancer risk.
@nl
P2093
P2860
P356
P1476
Serum high-density lipoprotein cholesterol, metabolic profile, and breast cancer risk.
@en
P2093
Anne-Sofie Furberg
Inger Thune
Tom Wilsgaard
P2860
P304
P356
10.1093/JNCI/DJH216
P407
P577
2004-08-01T00:00:00Z